SRRK

Scholar Rock Holding Corporation

9.11 USD
-0.10 (-1.09%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Scholar Rock Holding Corporation stock is down -37.9% since 30 days ago. The next earnings date is Aug 7, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 16.67% of the previous 6 May’s closed higher than April. In the last 2 Unusual Options Trades, there were 2 PUTs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
15 May 19:53 18 Oct, 2024 15.00 PUT 116 30
28 May 13:34 21 Jun, 2024 12.50 PUT 120 269

About Scholar Rock Holding Corporation

Scholar Rock Holding Corporation focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin, and SRK-181, which is in Phase 1 clinical trials. It is also developing a pipeline of novel product candidates with potential to transform the lives of patients.

  • HC Wainwright & Co.
    Thu May 23, 06:17
    buy
    confirm
  • HC Wainwright & Co.
    Wed May 8, 09:44
    buy
    confirm